#FDA approvals Dec. 2022: AbbVie’s #Vraylar, Nov #FDA approvals Dec. 2022: AbbVie’s #Vraylar, Novo Nordisk’s #Wegovy, plus #Briumvi, #Sunlenca, Genentech’s… https://t.co/TLqdBSOmRx